The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers
暂无分享,去创建一个
T. Pufe | F. Paulsen | W. Petersen | M. Tsokos | R. Mentlein
[1] W. Petersen,et al. The angiogenic peptide vascular endothelial growth factor is expressed in foetal and ruptured tendons , 2001, Virchows Archiv.
[2] T. Pufe,et al. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. , 2001, The Journal of rheumatology.
[3] T. Pufe,et al. Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cells. , 2001, Brain research. Molecular brain research.
[4] G. Sibbald,et al. Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[5] S. Carta,et al. Pressure ulcer research issues in surgical patients. , 2000, Advances in skin & wound care.
[6] Jerry S. Vandeberg,et al. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. , 2000, Annals of surgery.
[7] K. Püschel,et al. Häufigkeit und Ausmaß einer Osteomyelitis bei höhergradigen Dekubitalulzera – Eine histomorphologische Analyse nach unentkalkter Präparation des Os sacrum , 2000, Rechtsmedizin.
[8] G. Onder,et al. Effect of topical application of nerve-growth factor on pressure ulcers , 1999, The Lancet.
[9] N. Ferrara. Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.
[10] Napoleone Ferrara,et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.
[11] L. Eckhart,et al. Reverse Transcription-Polymerase Chain Reaction Products of Alternatively Spliced mRNAs Form DNA Heteroduplexes and Heteroduplex Complexes* , 1999, The Journal of Biological Chemistry.
[12] J. Held-Feindt,et al. Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells. , 1999, Brain research. Molecular brain research.
[13] G. Neufeld,et al. Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] T. K. Hunt,et al. The future of recombinant growth factors in wound healing. , 1998, American journal of surgery.
[15] G. Siemeister,et al. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression , 1997, Oncogene.
[16] Mayumi Ono,et al. Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells , 1996, The Journal of Biological Chemistry.
[17] M. Klagsbrun,et al. Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.
[18] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[19] W. Kenney,et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. , 1995, The Journal of clinical investigation.
[20] J. Rossant,et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.
[21] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[22] J. Erusalimsky,et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.
[23] N. Olsen,et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.
[24] D Norton,et al. Calculating the risk: reflections on the Norton Scale. , 1989, Decubitus.
[25] D. E. Sharland,et al. The Management and Prevention of Pressure Sores , 1982 .
[26] J. D. Shea. Pressure sores: classification and management. , 1975, Clinical orthopaedics and related research.
[27] M. Tsokos,et al. Pressure sores: epidemiology, medico-legal implications and forensic argumentation concerning causality , 2000, International Journal of Legal Medicine.
[28] J. Haalboom,et al. Pressure-induced skin lesions in pigs: reperfusion injury and the effects of vitamin E. , 2000, Journal of wound care.
[29] P. Vogt,et al. [Clinical application of growth factors and cytokines in wound healing]. , 2000, Zentralblatt fur Chirurgie.
[30] G. Bennett,et al. Pressure ulcers: prevalence, etiology, and treatment modalities. A review. , 1994, American journal of surgery.